Case number 2:23-cv-01285
ADVERIO PHARMA GMBH et al v. ALEMBIC PHARMACEUTICALS LIMITED et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 20, 2023 | 26 | LETTER ORDER: Initial Conference set for 8/7/2023 at 12:00 PM before Magistrate Judge Leda D. Wettre. Signed by Magistrate Judge Leda D. Wettre on 6/20/23. (LM, ) (Entered: 06/20/2023) (6) |
| Jun 14, 2023 | N/A | Clerk's Text Order - The document 25 Application for Clerk's Order to Ext Answer/Proposed Order submitted by Plaintiffs / Counter Defendants BAYER HEALTHCARE PHARMACEUTICALS INC., ADVERIO PHARMA GMBH, BAYER AG has been GRANTED. The answer due date has been set for 7/14/2023. (dam) (Entered: 06/14/2023) (0) |
| Jun 13, 2023 | 25 | Application and Proposed Order for Clerk's Order to extend time to answer as to Adverio Pharma GmbH, Bayer AG and Bayer HealthCare Pharmaceuticals Inc... (CHEVALIER, CHARLES) (Entered: 06/13/2023) (2) |
| Jun 9, 2023 | 24 | ANSWER to Complaint , COUNTERCLAIM against ADVERIO PHARMA GMBH, BAYER AG, BAYER HEALTHCARE PHARMACEUTICALS INC. by ALEMBIC PHARMACEUTICLAS, INC., ALEMBIC PHARMACEUTICALS LIMITED. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(EKINER, KAAN) (Entered: 06/09/2023) (0) |
| May 18, 2023 | 23 | STIPULATION AND ORDER extending time to respond through 6/9/2023. Signed by Magistrate Judge Leda D. Wettre on 5/18/2023. (lag, ) (Entered: 05/18/2023) (2) |
| May 17, 2023 | 22 | STIPULATION and Proposed Order for Extension of Time for Defendants to Respond to Complaint by ALEMBIC GLOBAL HOLDING SA, ALEMBIC PHARMACEUTICALS LIMITED, ALEMBIC PHARMACEUTICLAS, INC.. (EKINER, KAAN) (Entered: 05/17/2023) (2) |
| May 12, 2023 | 19 | Notice of Request by Pro Hac Vice W. Blake Coblentz to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14312334.) (EKINER, KAAN) (Entered: 05/12/2023) (2) |
| May 12, 2023 | 20 | Notice of Request by Pro Hac Vice Aaron S. Lukas to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14312350.) (EKINER, KAAN) (Entered: 05/12/2023) (2) |
| May 12, 2023 | 21 | Notice of Request by Pro Hac Vice Keri L. Schaubert to receive Notices of Electronic Filings. ( Pro Hac Vice fee $ 150 receipt number ANJDC-14312354.) (EKINER, KAAN) (Entered: 05/12/2023) (2) |
| May 12, 2023 | N/A | Pro Hac Vice counsel, W. BLAKE COBLENTZ, KERI L. SCHAUBERT and AARON S. LUKAS, has been added to receive Notices of Electronic Filing. Pursuant to L.Civ.R. 101.1, only local counsel are entitled to sign and file papers, enter appearances and receive payments on judgments, decrees or orders. (lag, ) (Entered: 05/12/2023) (0) |
| May 11, 2023 | 18 | ORDER admitting W. Blake Coblentz, Aaron S. Lukas, and Keri L. Schaubert Pro Hac Vice. Signed by Magistrate Judge Leda D. Wettre on 5/11/2023. (lag, ) (Entered: 05/11/2023) (2) |
| May 10, 2023 | 17 | Letter from Kaan Ekiner to the Honorable Leda D. Wettre, U.S.M.J. re Pro Hac Vice Application on Consent. (Attachments: # 1 Certification of Kaan Ekiner, # 2 Certification of W. Blake Coblentz, # 3 Certification of Aaron S. Lukas, # 4 Certification of Keri L. Schaubert, # 5 Text of Proposed Order)(EKINER, KAAN) (Entered: 05/10/2023) (0) |
| May 9, 2023 | 16 | NOTICE of Appearance by CHARLES H. CHEVALIER on behalf of ADVERIO PHARMA GMBH, BAYER AG, BAYER HEALTHCARE PHARMACEUTICALS INC. (CHEVALIER, CHARLES) (Entered: 05/09/2023) (1) |
| May 8, 2023 | 15 | STIPULATION AND ORDER extending time for defendants to respond to complaint through 5/19/2023. Signed by Magistrate Judge Leda D. Wettre on 5/8/2023. (lag, ) (Entered: 05/08/2023) (2) |
| May 5, 2023 | 14 | STIPULATION and Proposed Order for Extension of Time for Defendants to Respond to Complaint by ALEMBIC GLOBAL HOLDING SA, ALEMBIC PHARMACEUTICALS LIMITED, ALEMBIC PHARMACEUTICLAS, INC.. (EKINER, KAAN) (Entered: 05/05/2023) (2) |
| May 3, 2023 | 12 | NOTICE of Appearance by KAAN EKINER on behalf of ALEMBIC GLOBAL HOLDING SA, ALEMBIC PHARMACEUTICALS LIMITED, ALEMBIC PHARMACEUTICLAS, INC. (EKINER, KAAN) (Entered: 05/03/2023) (3) |
| May 3, 2023 | 13 | Corporate Disclosure Statement by ALEMBIC GLOBAL HOLDING SA, ALEMBIC PHARMACEUTICALS LIMITED, ALEMBIC PHARMACEUTICLAS, INC. identifying Alembic Pharmaceuticals Limited as Corporate Parent.. (EKINER, KAAN) (Entered: 05/03/2023) (3) |
| Mar 17, 2023 | 11 | TEXT ORDER REASSIGNING CASE. Case reassigned to Judge Esther Salas for all further proceedings. Judge Susan D. Wigenton no longer assigned to case. So Ordered by Chief Judge Renee Marie Bumb on 03/17/23. (aw, ) (Entered: 03/17/2023) (0) |
| Mar 13, 2023 | 8 | WAIVER OF SERVICE Returned Executed by BAYER HEALTHCARE PHARMACEUTICALS INC., BAYER AG. ALEMBIC PHARMACEUTICALS LIMITED waiver sent on 3/9/2023, answer due 5/8/2023. (DELORENZI, DAVID) (Entered: 03/13/2023) (1) |
| Mar 13, 2023 | 9 | WAIVER OF SERVICE Returned Executed by BAYER HEALTHCARE PHARMACEUTICALS INC., BAYER AG. ALEMBIC GLOBAL HOLDING SA waiver sent on 3/9/2023, answer due 5/8/2023. (DELORENZI, DAVID) (Entered: 03/13/2023) (1) |
| Mar 13, 2023 | 10 | WAIVER OF SERVICE Returned Executed by BAYER HEALTHCARE PHARMACEUTICALS INC., BAYER AG. ALEMBIC PHARMACEUTICLAS, INC. waiver sent on 3/9/2023, answer due 5/8/2023. (DELORENZI, DAVID) (Entered: 03/13/2023) (1) |
| Mar 9, 2023 | 5 | AO120 Patent Form filed. (Attachments: # 1 Complaint) (lag, ) (Entered: 03/09/2023) (0) |
| Mar 9, 2023 | 6 | SUMMONS ISSUED as to ALEMBIC GLOBAL HOLDING SA, ALEMBIC PHARMACEUTICALS LIMITED, ALEMBIC PHARMACEUTICLAS, INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (lag, ) (Entered: 03/09/2023) (2) |
| Mar 9, 2023 | 7 | NOTICE of Appearance by CHRISTINE A. GADDIS on behalf of ADVERIO PHARMA GMBH, BAYER AG, BAYER HEALTHCARE PHARMACEUTICALS INC. (GADDIS, CHRISTINE) (Entered: 03/09/2023) (1) |
| Mar 8, 2023 | N/A | Case assigned to Judge Susan D. Wigenton and Magistrate Judge Leda D. Wettre. (jr) (Entered: 03/08/2023) (0) |
| Mar 7, 2023 | 1 | COMPLAINT against ALEMBIC GLOBAL HOLDING SA, ALEMBIC PHARMACEUTICALS LIMITED, ALEMBIC PHARMACEUTICLAS, INC. ( Filing and Admin fee $ 402 receipt number ANJDC-14138004) , Related Case Selected, filed by ADVERIO PHARMA GMBH, BAYER HEALTHCARE PHARMACEUTICALS INC., BAYER AG. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet, # 3 Certification pursuant to Local Civil Rule 11.2)(DELORENZI, DAVID) (Entered: 03/07/2023) (0) |
| Mar 7, 2023 | 2 | Corporate Disclosure Statement by ADVERIO PHARMA GMBH identifying BAYER AG as Corporate Parent.. (DELORENZI, DAVID) (Entered: 03/07/2023) (2) |
| Mar 7, 2023 | 3 | Corporate Disclosure Statement by BAYER HEALTHCARE PHARMACEUTICALS INC. identifying BAYER AG as Corporate Parent.. (DELORENZI, DAVID) (Entered: 03/07/2023) (2) |
| Mar 7, 2023 | 4 | Corporate Disclosure Statement by BAYER AG identifying NONE as Corporate Parent.. (DELORENZI, DAVID) (Entered: 03/07/2023) (2) |
